HEPS
D-Market Elektronik Hizmetler ve Ticaret A.S.
HEPS has the edge over LCID overall on the model score.
LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
HEPS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Under pressure | |
| Strong |
HEPS's revenue and balance sheet are currently healthy, but its profitability and cash flow are under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HEPS PE Valuation
HEPS has no meaningful PE right now: it lost money over the past year.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
HEPS Forward outlook
There aren't enough analyst estimates for HEPS to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HEPS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.44 | -$0.31 |
| Q1 2026 | -$0.39 | -$0.28 |
| Q4 2025 | -$0.35 | -$0.26 |
| Q3 2025 | -$0.19 | -$0.10 |
| Q2 2025 | -$0.13 | -$0.05 |
| Q1 2025 | -$0.11 | -$0.10 |
| Q4 2024 | -$0.09 | -$0.06 |
| Q3 2024 | -$0.09 | -$0.08 |
HEPS lost $0.44 per share over the past year, and its loss has widened in each of the last six quarters.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over HEPS on earnings, with more consistent year-over-year improvement.
HEPS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $453.9M | +36% |
| Q1 2026 | $460.4M | +61% |
| Q4 2025 | $603.7M | +48% |
| Q3 2025 | $396.4M | +63% |
| Q2 2025 | $333.2M | +23% |
| Q1 2025 | $286.3M | -7.9% |
| Q4 2024 | $406.7M | +46% |
| Q3 2024 | $243.6M | +1.7% |
HEPS's revenue has grown year over year for five quarters in a row: $454M last quarter, up 36% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.9% | -3.1 points |
| Q1 2026 | -1.9% | +1.9 points |
| Q4 2025 | 0.9% | +0.3 points |
| Q3 2025 | -3% | -3.2 points |
| Q2 2025 | 0.2% | +0.5 points |
| Q1 2025 | -3.8% | -2.9 points |
| Q4 2024 | 0.7% | +2.6 points |
| Q3 2024 | 0.3% | +2.3 points |
HEPS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over HEPS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
HEPS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $29.3M | -56% |
| Q1 2026 | -$61.5M | -$60.6M |
| Q4 2025 | $14.9M | +$15.4M |
| Q3 2025 | $438.9K | +30% |
| Q2 2025 | $66.5M | +$67.4M |
| Q1 2025 | -$928.4K | -510% |
| Q4 2024 | -$582.5K | -133% |
| Q3 2024 | $337.1K | -66% |
HEPS has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
HEPS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.8% | +3.1M shares |
| 1 year | +15% | +47.7M shares |
| 3 years | +14% | +44.2M shares |
| 5 years | +14% | +44.5M shares |
| Available history | +14% | +44.5M shares |
HEPS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
HEPS hasn't bought back shares in the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
HEPS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -2.3x | Net Cash |
| Q1 2026 | -2.8x | Net Cash |
| Q4 2025 | -6.3x | Net Cash |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.4x | Net Cash |
HEPS has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HEPS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.7 | Neutral |
| Stochastic | 60.1 | Neutral |
HEPS's weekly RSI is 50 (neutral) and its Stochastic is 60 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HEPS PE vs Consumer Cyclical Sector
| Metric | HEPS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
HEPS has no meaningful PE right now: it lost money over the past year.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
HEPS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 1.1% above |
| 20 week MA | $2.73 | 0.7% below |
| 50 week MA | $2.73 | 0.7% below |
| 100 week MA | $2.79 | 2.9% below |
| 200 week MA | $2.28 | 19% above |
HEPS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
HEPS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $14.1 | $2.05 | -85% |
| 2022 | $2.05 | $0.69 | -66% |
| 2023 | $0.69 | $1.80 | +161% |
| 2024 | $1.80 | $3.26 | +81% |
| 2025 | $3.26 | $2.52 | -23% |
| 2026 YTD | $2.52 | $2.71 | +7.5% |
HEPS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.